Moschouris Hippocrates, Stamatiou Konstantinos, Tzamarias Spyros, Frigkas Konstantinos, Spanomanolis Nektarios, Isaakidou Ivlitta, Dimitroula Effrosyni, Spiliopoulos Stavros, Brountzos Elias, Malagari Katerina
Radiology, Tzanio General Hospital, Piraeus, GRC.
Urology, Tzanio General Hospital, Piraeus, GRC.
Cureus. 2023 Sep 25;15(9):e45941. doi: 10.7759/cureus.45941. eCollection 2023 Sep.
Background This study aimed, first, to angiographically investigate and analyze prostatic artery (PA) origin in a Greek male population with benign prostatic hyperplasia (BPH) treated with prostatic artery embolization (PAE) and, second, to correlate prostatic arterial anatomy with technical and clinical aspects of PAE. Methodology This was a retrospective study of BPH patients who underwent PAE in a single tertiary center in Greece from June 2019 to July 2022. For the first part of the study, PA was imaged with computed tomography angiography (CTA) before PAE and with digital subtraction angiography (DSA) during PAE in all patients. A widely accepted system for the classification of PA origin was applied. Type I, a common origin of PA and superior vesical artery (SVA) from the anterior division of internal iliac artery (IIA). Type II, PA originating from the anterior division of IIA, separate from, and inferior to SVA. Type III, the origin of PA from the obturator artery. Type IV, the origin of PA from the internal pudendal artery. Type V, rarer origins of PA. For the second part of the study, a subgroup of patients from the first part (treated with the same PAE protocol and free of vascular pathology that could have interfered with the technical success of PAE) was selected. In this subgroup, differences in PA origin were correlated with technical aspects (feasibility of catheterization of PA, fluoroscopy time (FT), dose area product (DAP)) and clinical outcomes of PAE. Results After the exclusion of four patients, 159 patients were included in the first part of the study. From a total of 355 PAs, 110 (31%) were compatible with type I, 58 (16.3%) type II, 45 (12.7%) type III, 110 (31%) type IV, and 32 (9%) type V. PA origin from an accessory internal pudendal artery was the most common among the rare origins of type V. Regarding the second part of the study (a subgroup of 101 patients selected to facilitate comparisons between the different types of PA origin), type I was associated with significantly more incidences of failed or difficult catheterization of the PA compared to all other types combined (27/64 vs. 18/138, p < 0.001). Types III, IV, and V showed a relatively low degree of technical difficulty. Patients with type I PA origin of at least one pelvic side (subgroup (I), n = 48) had significantly longer FT and DAP compared to the rest (subgroup (O), n = 53). Clinical success rates of PAE were slightly lower for the subgroup (I), although the difference was not statistically significant (75.8% vs. 83.8% at 18 months post-PAE, p = 0.137). No major complications were observed. Conclusions This is the first study of PA origin in Greece. It was demonstrated that types I and IV of PA origin were the most common and had the same prevalence. Type I showed significantly higher technical difficulty compared to the others, but had no significant impact on the clinical outcomes of PAE.
背景 本研究旨在:第一,通过血管造影术对希腊接受前列腺动脉栓塞术(PAE)治疗的良性前列腺增生(BPH)男性人群的前列腺动脉(PA)起源进行调查和分析;第二,将前列腺动脉解剖结构与PAE的技术和临床方面进行关联。方法 这是一项对2019年6月至2022年7月在希腊一个单一三级中心接受PAE的BPH患者的回顾性研究。在研究的第一部分,所有患者在PAE前通过计算机断层扫描血管造影(CTA)对PA进行成像,并在PAE期间通过数字减影血管造影(DSA)成像。应用一种广泛接受的PA起源分类系统。I型,PA和膀胱上动脉(SVA)共同起源于髂内动脉(IIA)前支。II型,PA起源于IIA前支,与SVA分开且在其下方。III型,PA起源于闭孔动脉。IV型,PA起源于阴部内动脉。V型,PA的罕见起源。在研究的第二部分,从第一部分的患者中选择了一个亚组(接受相同的PAE方案且无可能干扰PAE技术成功的血管病变)。在这个亚组中,PA起源的差异与技术方面(PA插管的可行性、透视时间(FT)、剂量面积乘积(DAP))和PAE的临床结果相关。结果 在排除4名患者后,159名患者被纳入研究的第一部分。在总共355条PA中,110条(31%)符合I型,58条(16.3%)符合II型,45条(12.7%)符合III型,110条(31%)符合IV型,32条(9%)符合V型。来自副阴部内动脉的PA起源是V型罕见起源中最常见的。关于研究的第二部分(选择101名患者的亚组以促进不同类型PA起源之间的比较),与所有其他类型合并相比,I型与PA插管失败或困难的发生率显著更高(27/64 vs. 18/138,p < 0.001)。III型、IV型和V型显示出相对较低的技术难度。至少一侧骨盆为I型PA起源的患者(亚组(I),n = 48)与其余患者(亚组(O),n = 53)相比,FT和DAP显著更长。PAE的临床成功率在亚组(I)中略低,尽管差异无统计学意义(PAE后18个月时为75.8% vs. 83.8%,p = 0.137)。未观察到重大并发症。结论 这是希腊关于PA起源的第一项研究。结果表明,PA起源的I型和IV型最常见且患病率相同。I型与其他类型相比技术难度显著更高,但对PAE的临床结果无显著影响。